Evidence map›Paper›PMID 35146214›Full record

ArticleAmerican journal of ophthalmology case reports2022

Recovery of vision after treatment of hemodialysis related bilateral optic nerve ischemia.

M Paez-Escamilla, A Abo-Zed, B Abramovitz, S T Stefko, E Waxman

Open access · goldAbstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

M Paez-EscamillaUniversity of Pittsburgh Medical Center, Department of Ophthalmology, United States.
A Abo-ZedRenal-Electrolyte Division, Department of Medicine at the University of Pittsburgh, United States.
B AbramovitzRenal-Electrolyte Division, Department of Medicine at the University of Pittsburgh, United States.
S T StefkoUniversity of Pittsburgh Medical Center, Department of Ophthalmology, United States.
E WaxmanUniversity of Pittsburgh Medical Center, Department of Ophthalmology, United States.
University of Pittsburgh Medical Center · USUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe present the case of a patient who lost light perception in both eyes after hemodialysis and subsequently recovered vision after treatment with erythropoietin and intravenous steroids. OBSERVATIONS: Our patient reported loss of light perception in both eyes (NLP) 2 hours after hemodialysis. Examination confirmed NLP vision, chronic retinal vascular changes, and no acute changes in optic nerve appearance. A presumptive diagnosis of posterior optic neuropathy was made. The patient was treated with erythropoietin and intravenous steroids according to the protocol of Nikkah. Over a period of 14 hours, he recovered vision to his baseline. CONCLUSIONS AND IMPORTANCE: Bilateral loss of light perception is a rare complication of hemodialysis. The presumed mechanism is posterior ischemic optic neuropathy. Prompt treatment with erythropoietin and intravenous steroids should be considered in similar situations that result in Posterior ischemic optic neuropathy (PION) related to procedure-based hypotension.

Indexed as

Diabetes mellitusEnd-stage renal diseaseErythropoietinHemodialysisPosterior ischemic optic neuropathyVisual loss

Identifiers

PMID35146214
PMCPMC8818521
OpenAlexW4210330003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.